Cortex Pharmaceuticals Inc. announced Thursday that it hasclosed on the sale of 13.75 million shares of common stock at$1 per share. The Irvine, Calif., company (NASDAQ:CORX)announced the purchase agreements last month (see BioWorld,Nov. 10). Billionaire George Soros was the primary investor,acquiring an 18 percent stake in the company through hisQuantum Fund.
(c) 1997 American Health Consultants. All rights reserved.